Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

0610008F07Rik Inhibitors

The non-coding RNA gene 0610008F07Rik, also known as Hnf4aos, has been identified as a significant player in the complex regulatory networks that govern gene expression in Mus musculus, or the common house mouse. This gene is intricately involved in the regulation of hepatic nuclear factor 4 alpha (HNF4α), a nuclear receptor protein that is critical for liver development and general liver function. The expression of 0610008F07Rik is notably higher in organs such as the liver and kidney, suggesting a specialized role in the physiological processes that take place within these tissues. The gene itself does not encode a protein but instead produces a non-coding RNA, which can play diverse roles in the regulation of other genes, including acting as a molecular sink for regulatory proteins, modifying the structure of chromatin, and altering the stability and translation of messenger RNAs.

In the quest to understand how the expression of genes like 0610008F07Rik can be controlled, various chemicals have been identified that could potentially serve as inhibitors, albeit indirectly. Compounds such as 5-Azacytidine and Trichostatin A target broad aspects of the epigenetic machinery, demethylating DNA and altering histone acetylation, respectively, which can lead to the downregulation of specific genes. Other chemicals, like Actinomycin D, directly inhibit the transcriptional machinery, offering a means to reduce RNA synthesis across the genome. Specific to the non-coding RNA category, α-Amanitin's potent inhibition of RNA polymerase II can lead to a decrease in the levels of ncRNA transcripts. Similarly, small molecule inhibitors targeting signal transduction pathways, such as Sirolimus, LY294002, PD98059, and SP600125, exhibit their ability to influence gene expression by inhibiting key kinases involved in cell growth and differentiation. These inhibitors, while affecting a wide range of cellular targets, suggest potential avenues for the selective downregulation of 0610008F07Rik expression through the disruption of signaling pathways and transcriptional control mechanisms that dictate ncRNA levels. It is through the nuanced understanding of these chemical-gene interactions that researchers may further decipher the role of 0610008F07Rik in cellular function.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine may downregulate the expression of 0610008F07Rik by incorporating into DNA during replication and causing the demethylation of gene regulatory regions, potentially leading to transcriptional silencing.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A could reduce the transcription of 0610008F07Rik by inhibiting histone deacetylase activity, resulting in an open chromatin state and transcriptional repression due to the failure of maintaining chromatin structure.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

RG108 might decrease the expression of 0610008F07Rik by blocking DNA methyltransferases, leading to reduced methylation on the gene′s promoter region, a marker often associated with gene silencing.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D can inhibit the transcription of 0610008F07Rik by intercalating into DNA, thereby obstructing the advancement of RNA polymerase along the DNA template.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

α-Amanitin might lead to a decrease in 0610008F07Rik levels by specifically inhibiting RNA polymerase II, the enzyme responsible for transcribing mRNA, snRNA, and some miRNAs.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin (Sirolimus) could downregulate the expression of 0610008F07Rik by inhibiting the mTOR pathway, which is crucial for the synthesis of several cellular proteins and ncRNAs.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic Acid might reduce the transcription of 0610008F07Rik through its role as an active metabolite of vitamin A, which binds to retinoic acid receptors and alters the transcription of target genes.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine has the potential to decrease the expression of 0610008F07Rik by disrupting endosomal acidification and autophagic processes, leading to altered cellular homeostasis and gene expression profiles.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

JQ1 could lead to the downregulation of 0610008F07Rik by competitively binding to bromodomains of BET proteins, thereby dislodging them from chromatin and suppressing the expression of genes under their control.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY 294002 has the potential to inhibit the expression of 0610008F07Rik by targeting PI3K, a key kinase in cellular signaling pathways, leading to a reduction in downstream transcriptional activities.